These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 20609352)
1. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. Wang H; Vardy LA; Tan CP; Loo JM; Guo K; Li J; Lim SG; Zhou J; Chng WJ; Ng SB; Li HX; Zeng Q Cancer Cell; 2010 Jul; 18(1):52-62. PubMed ID: 20609352 [TBL] [Abstract][Full Text] [Related]
2. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246 [TBL] [Abstract][Full Text] [Related]
4. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo. Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression. Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483 [TBL] [Abstract][Full Text] [Related]
6. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer. Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969 [TBL] [Abstract][Full Text] [Related]
7. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108 [TBL] [Abstract][Full Text] [Related]
8. [Effects of phosphatase of regenerating liver cell-3 gene silence by RNA interference on the expression of matrix metalloproteinases-2,-9 in human colon cancer cells]. Fan Y; Zhang YL; Zheng S Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):477-81. PubMed ID: 18803055 [TBL] [Abstract][Full Text] [Related]
9. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Fiordalisi JJ; Keller PJ; Cox AD Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666 [TBL] [Abstract][Full Text] [Related]
10. PRL-3 phosphatase is implicated in ovarian cancer growth. Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771 [TBL] [Abstract][Full Text] [Related]
11. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation]. Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692 [TBL] [Abstract][Full Text] [Related]
12. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells. Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018 [TBL] [Abstract][Full Text] [Related]
13. Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer. Cai SR; Wang Z; Chen CQ; Wu WH; He YL; Zhan WH; Zhang CH; Cui J; Wu H Chin Med J (Engl); 2008 Dec; 121(24):2534-8. PubMed ID: 19187591 [TBL] [Abstract][Full Text] [Related]
14. [Construction of a lentiviral vector for RNA interference of PRL-3 gene and its stable expression in SW480 cells]. Liu YH; Li JM; Zhou J; Ding YQ Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):509-12. PubMed ID: 18495578 [TBL] [Abstract][Full Text] [Related]
15. Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma. Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Watanabe M Int J Cancer; 2010 Aug; 127(3):543-54. PubMed ID: 19960436 [TBL] [Abstract][Full Text] [Related]
16. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells. Wang L; Shen Y; Song R; Sun Y; Xu J; Xu Q Mol Pharmacol; 2009 Dec; 76(6):1238-45. PubMed ID: 19779032 [TBL] [Abstract][Full Text] [Related]
17. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor. Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127 [TBL] [Abstract][Full Text] [Related]
18. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma]. Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237 [TBL] [Abstract][Full Text] [Related]
19. PRL-3: a metastasis-associated phosphatase in search of a function. Bessette DC; Wong PC; Pallen CJ Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829 [TBL] [Abstract][Full Text] [Related]
20. THAP11, a novel binding protein of PCBP1, negatively regulates CD44 alternative splicing and cell invasion in a human hepatoma cell line. Lian WX; Yin RH; Kong XZ; Zhang T; Huang XH; Zheng WW; Yang Y; Zhan YQ; Xu WX; Yu M; Ge CH; Guo JT; Li CY; Yang XM FEBS Lett; 2012 May; 586(10):1431-8. PubMed ID: 22673507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]